INFUSYSTEM HOLDINGS, INC (INFU)

Healthcare · Medical Devices · Price $12.09
Updated: Aug 21, 2026
Net Income (TTM)
$8.5M
Trailing 12 Months
Growth Rate
100.00%
Log-Linear Regression (16Q)
Price/Earnings
30.2x
Valuation Multiple
EPS (Diluted)
$0.40
Net Income / Shares
Net Margin
5.96%
Profitability

📈 Net Income History (16 Quarters)

🧮 INFU Net Income Breakdown

Net Income = Revenue - All Expenses - Taxes - Interest
Revenue (Top Line) $143.3M
Less: Cost of Revenue → Gross Profit $82.4M
Less: Operating Expenses → Operating Income $13.3M
Less: Interest Expense $1.1M
Less: Income Tax Expense $3.7M
Equals: Net Income (Bottom Line) $8.5M

Understanding Net Income

Net income, also called the "bottom line" or net profit, is the money a company keeps after paying all expenses including cost of goods, operating costs, interest, and taxes. For INFU, the trailing twelve month net income is $8.5M.

Why Net Income Matters

Net income is the ultimate measure of accounting profitability. It determines earnings per share (EPS), affects stock valuations through the P/E ratio, and represents the theoretical amount available to shareholders. However, net income can be influenced by accounting choices, which is why value investors often look at cash flow metrics alongside it.

INFU's net income growth rate of 100.00% (based on log-linear regression of 16 quarters) indicates exceptional profit growth, often valued at premium multiples.

Net Income vs Cash Flow Metrics

Free Cash Flow: $23.0M →

Actual cash generated after capital expenditures. FCF often differs from net income due to depreciation, working capital changes, and capex timing.

Owner Earnings: $23.0M →

Buffett's preferred metric that adds back depreciation but subtracts maintenance capex. Often considered more accurate than net income.

EPS (Diluted): $0.40 →

Net income divided by diluted shares outstanding. The primary driver of the P/E ratio used in valuations.

Revenue: $143.3M →

The top line that net income is derived from. Net margin shows what percentage of revenue becomes profit.

P/E Ratio Analysis

INFU's P/E ratio of 30.2x means investors pay $30.23 for every $1 of annual earnings. A P/E between 25-40 suggests investors expect above-average earnings growth.

Net Margin: Profitability Efficiency

Net margin of 5.96% shows what percentage of INFU's revenue converts to profit after all costs. Net margins between 5-10% are common in competitive industries with thinner profits.

Summary: INFU Net Income Trend

INFUSYSTEM HOLDINGS, INC (INFU) has a net margin of 5.96%, which Zyberno classifies as acceptable for a Healthcare company — within the 4–10% range Zyberno considers typical for healthcare businesses where R&D amortization, legal costs, and tax structures shape net margins. Net income grew at 100.00% annually — significantly above the 20% threshold Zyberno associates with high-growth businesses. For complete financial analysis, view the full INFU stock report on Zyberno.

Frequently Asked Questions

What is INFU's current net income?

INFUSYSTEM HOLDINGS, INC's TTM net income is $8.5M, growing at 100.00% annually — significantly above the 20% threshold Zyberno associates with high-growth businesses.

Is INFU's net income growing?

INFUSYSTEM HOLDINGS, INC (INFU) has a net margin of 5.96%, which Zyberno classifies as acceptable for a Healthcare company — within the 4–10% range Zyberno considers typical for healthcare businesses where R&D amortization, legal costs, and tax structures shape net margins. Net income grew at 100.00% annually — significantly above the 20% threshold Zyberno associates with high-growth businesses.

What is INFU's net profit margin?

INFUSYSTEM HOLDINGS, INC (INFU) has a net margin of 5.96%, which Zyberno classifies as acceptable for a Healthcare company — within the 4–10% range Zyberno considers typical for healthcare businesses where R&D amortization, legal costs, and tax structures shape net margins. Net income grew at 100.00% annually — significantly above the 20% threshold Zyberno associates with high-growth businesses.

What is INFU's P/E ratio?

INFU's P/E ratio is 30.2x, meaning the market values the company at 30.2 times its annual earnings.

How does net income differ from free cash flow?

Net income is an accounting measure that includes non-cash items like depreciation, while free cash flow shows actual cash generated. INFU's net income is $8.5M versus free cash flow of $23.0M. Large differences often indicate significant capital expenditures or working capital changes.

📊 Valuation Trilogy
Three interconnected metrics built on Owner Earnings
💎
Intrinsic Value
DCF Fair Value
$14.76
🛡️
Margin of Safety
Valuation Gap
18.1%
🎯
Expected Return
Projected Annual
4.7%
Click any metric for full methodology and detailed analysis

📊 Full INFU Stock Report

See INFU's intrinsic value, margin of safety, DCF valuation, and complete financial analysis with 250+ metrics.

💵 INFU Free Cash Flow

Compare to Free Cash Flow which subtracts all capital expenditures, not just maintenance CapEx.

💰 INFU Owner Earnings

Compare to Buffett's Owner Earnings metric which uses maintenance CapEx instead of total capital expenditures.

📈 INFU Earnings Per Share

Analyze EPS trends, P/E ratio, earnings yield, and per-share profitability metrics.

🎯 INFU Earnings Surprise (SUE)

See whether INFU is beating or missing its own earnings trend — Standardized Unexpected Earnings and post-earnings drift.

📊 INFU Revenue

Analyze revenue trends, growth rate, P/S ratio, and top-line sales performance.

💰 INFU Net Income

Analyze the bottom-line profit, P/E ratio, and net profit margin trends.

🔶 INFU Operating Income

Analyze EBIT, operating margin, and core business profitability before interest and taxes.

💜 INFU Gross Profit

Analyze gross margin, pricing power, and profitability before operating expenses.

View Full INFU Report Find More Quality Stocks
Scroll to Top